This biotechnology company is focused on developing novel therapies for heart failure. The company is using stem cell technology and a patient Biobank licensed from a top ten University to generate human heart cell disease models to accelerate drug discovery and development. To date the company has generated USD 1.75 million in revenue from pharmaceutical companies, the USFDA and grants. It has also progressed its first product candidate into animal trials.
Asking Price Available On Request
Profit Available On Request
You May Also Like
Biopharmaceutical Co. Seeking a Strategic Partner #456453 posted Oct 24, 2016
- California, United States
- Available On Request
The company’s proprietary technologies enable the harvesting and chemical deconvolution of sufficient quantities of unstudied aquatic microorganisms to unlock the enormous novel chemical diversity found in the environment. This chemistry is captured in simplified samples for screening in state-of-the-art...
Working Interest in Bioscience Stem Cell Research #457087 posted Nov 1, 2016
- Arizona, United States
We have an investment that will make you money while helping others so everyone wins. What are we doing? We're building hospitals and research facilities for non embryonic stem cell research. Based on past performance we're anticipating a minimum of a 30% return on your investment per year over...
Thriving Colorado Soils Engineering Firm for Sale #451055 posted Aug 5, 2016
- Colorado, United States
Rapidly growing Colorado soils engineering business with a primary service area along Colorado's Front Range as well as 1 in-state satellite location. The business services both the residential & commercial markets and and enjoys nearly 90% of its work coming from repeat clients. Additional growth...
Disclaimer: MergerNetwork has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.